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at an acceptable cost. The objective of this study was to perform a rapid-HTA to 
evaluate the effectiveness of integrated care in reducing the mortality rate of breast 
cancer. Methods: A literature review was performed via PubMed, LILACS, the 
Cochrane Library, Center of Reviews and Dissemination, and REBRATS databases. All 
studies that met the inclusion criteria were appraised according to the GRADE and 
their level of evidence according to the Oxford Centre for Evidence Based Medicine. 
This HTA was performed following the “Rapid-HTA Guideline” published by the 
Brazilian Ministry of Health. Results: 242 studies were retrieved among those 
databases. 3 cohort studies and 1 systematic review met the inclusion criteria. One 
cohort study associated a reduction in the mortality rate, statistically significant, 
after the implementation of the breast cancer integrated care. The systematic review 
concluded that there are few high quality studies evaluating the impact of integrated 
care on the breast cancer mortality. However, its authors didn’t challenge the impact 
of integrated care on the breast cancer management nor its potential psychosocial 
benefits. Intrinsically, they stated, this type of disease management is associated 
to a low rate of mortality, but there is a lack of high quality studies. ConClusions: 
There are few studies assessing the effectiveness of breast cancer integrated care 
programs in reducing the mortality rate among those women. The final recom-
mendation is weak in favor of this health technology and we suggest a systematic 
review to search and evaluate the existing evidence.
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THe AffordAble CAre ACT And PHArmACy benefiT mAnAgerS: HeAlTH 
CAre exCHAngeS And ProjeCTed ouTComeS
Shamseddine N.1, Lovett A.W.1, Beaty S.2
1Mercer University College of Pharmacy, Atlanta, GA, USA, 2Express Scripts, St. Louis, MO, USA
objeCtives: The Affordable Care Act (ACA) was signed into law on March 23, 2010. 
The ACA was developed to increase affordability and accessibility to health care. 
The purpose of this review was to provide an overview of the impact of the ACA 
on pharmacy benefit managers (PBMs) with respect to benefit design changes, 
health care exchanges and challenges. Methods: PubMed, Google Scholar, APhA 
and AMCP websites were searched for articles from 2008 to 2013. This timeframe 
was selected because the ACA became officially recognized in 2010, when signed 
into law. Keywords used in the search were “pharmacy model”, “affordable care 
act”, “pharmacy benefit”, “benefit design changes”, “health care exchange”, and 
“outcomes.” Each reference was evaluated against the following inclusion crite-
ria using a step-wise approach; 1) the article included information on formulary 
changes, health care exchanges or projected outcomes 2) the article mentioned 
benefit designs and pharmacy benefit managers. Articles were summarized based 
upon publication year, methods and findings. Results: A total of 24 articles were 
retrieved. Studies show that there will be 25-30 million newly insured patients over 
7-8 years as a result of the ACA. PBMs will continue to be interested in increasing 
coverage of generic products on plan formularies. The number of medications and 
types of diseases covered through the growth of specialty pharmacy is also projected 
to increase. Under the ACA exchanges, PBMs are required to confidentially disclose 
the percent of all prescriptions provided through retail pharmacies and the types of 
rebates and discounts received. Although challenging, PBMs can expect increases in 
mergers, creating larger PBM companies. ConClusions: With an increase in the 
number of members covered and types of coverage offered, the Affordable Care Act 
is projected to have positive effects on the growth and expansion of services offered 
by PBMs. However, PBMs may face challenges accommodating larger populations.
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imPACT of eduCATionAl inTervenTion on QuAliTy of life of PATienTS 
neAring end of life: An evidenCe bASed AnAlySiS
Nevis I.F., Sikich N., Holubowich C.
on behalf of the Health Quality Ontario Expert Panel on End-of-Life Care, Health Quality Ontario, 
Toronto, ON, Canada
objeCtives: To systematically review studies that include educational interven-
tions for health care providers, patients nearing the end-of-life (EoL), and their car-
egivers to improve patient or caregiver quality of life (QoL). Methods: This review 
was conducted according to published guidelines using a pre-specified protocol. 
Patients nearing EOL were defined as having a progressive, life-threatening disease 
with minimal possibility of obtaining remission, stabilization or modification of the 
course of illness. Primary studies including any educational intervention in EoL care 
among health care providers, patients and caregivers measuring patient or caregiver 
QoL using validated scales were included. Results: Our search of 11 databases 
revealed 2468 citations. After duplicate removal, title and abstract screening, we 
reviewed 71 full text of which eight were included in the review. There were five 
randomised trials, two cohort studies and one quasi experimental study among 
the eight included studies. Five studies were from United States, one each from 
Spain, Saudi Arabia and China. Patient population included those with advanced 
cancer in five studies (4 RCT’S and 1 cohort study) and advanced chronic disease in 
three studies (1 cluster randomised, 1 quasi-experimental and 1 cohort study). The 
educational intervention was described among clinicians, nurses, EoL patients and 
their caregivers. Comparators were usual/standard care in five studies with a pre-
post impact evaluation in three other studies. All included studies defined and used 
validated scales to measure QoL. Patient QoL was reported in seven of the included 
studies, of which four studies showed improvement (P< 0.001) and three showed 
no significant change (p> 0.05) in patient’s QoL. Of the four studies that reported 
caregiver QoL, three showed improved QoL whereas one study showed decline in 
caregivers QoL (p= 0.02). ConClusions: This review may help shape Ontario health 
policy to provide appropriate education to anyone involved in EoL care.
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mAmmogrAPHy PreSCriPTionS in uniTed STATeS PrimAry CAre SeTTing – 
PHySiCiAn’S ComPliAnCe WiTH guidelineS
Suryavanshi M., Lairson D.R., Rajan S.S.
University of Texas Health Science Center, School of Public Health, Houston, TX, USA
TIP-records, time period, beneficiary age, gender, and drug plan (MA-PD, PDP). A 
generalized linear mixed model was fitted for the assessment, using AIC for model 
selection. Results: Each additional TIP-record generated was significantly associ-
ated with a higher total drug cost (p < .0001); however, this effect was attenuated 
over time, as would be expected when the TIP-record was successfully acted upon. 
A successful TIP-record was associated with an 18% reduction in cost at the begin-
ning of the study, falling to 7% at 18 months. On average, MA-PD beneficiaries had 
a cost which was 1.62 times higher than those from the PDP; male beneficiaries had 
an average cost which was 4.8% higher than their counterparts. ConClusions: 
Cost-management TIP-records demonstrated a significant decrease in total pre-
scription drug cost upon successful completion, suggesting targeted medication 
reviews could be used as a drug cost saving strategy for Medicare Part D plans.
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uSe of ACuPunCTure And ASSoCiATed fACTorS Among THe elderly: A 
reTroSPeCTive PoPulATion-bASed CoHorT STudy
Lin H.W.1, Chen L.P.1, Lin C.H.2, Chou C.Y.2
1China Medical University, Taichung, Taiwan, 2China Medical University Hospital, Taichung, 
Taiwan
objeCtives: While the use of acupuncture services covered by National Health 
Insurance (NHI) in Taiwan increased, it is unclear how reasonable its utilization is. 
The aim of this study was to explore the acupuncture service utilization among the 
elderly and its potential contributing factors. Methods: The retrospective cohort 
study was conducted using two million random samples of Taiwan National Health 
Insurance Research Databases. Those elderly patients without cancer diseases and 
ever used acupuncture services among the Chinese medicine (CM) users in 2008 
were considered as acupuncture users. Their counterpart non-acupuncture elderly 
CM users were identified based upon the pre-specified propensity score matching 
approach. The demographic characteristics, disease statuses, health care utiliza-
tion, anti-blood clotting medications, pain medications among these two groups 
were compared using descriptive statistics, Chi-square and ANOVA. The univariate 
and multivariate logistic regression tests were performed to explore the factors 
associated with the ever use of acupuncture services. Results: Of 47,273 elderly 
patients ever used CM service , 12520 (32.3%) ever utilized acupuncture services 
in 2008. 12,494 elderly patients in each group were identified. After adjusting for 
other factors, those CM use elderly who made outpatients visits more than 2 times, 
with neurovascular diseases, diabetes mellitus, lower back pain, ever took aspirin, 
warfarin, NSAID, gabapentin during six months before the first use of CM tended 
to use acupuncture services. In contrast, those CM use elderly who were aged 
75 to 84, prescribed with more than 10 items of medications, with chronic lung 
disorders, osteoporosis tended not to use acupuncture services. ConClusions: 
Approximately one-third of CM use elderly ever made acupuncture services. More 
attention should be made towards those patients who made more outpatient visits, 
with certain chronic disorders and ever took blood-clotting and pain medications. 
Further study to explore the corresponding outcomes of acupuncture uses among 
the elderly is needed.
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WHAT deTerminAnTS HelP PrediCT reAdmiSSion in A TeACHing HoSPiTAl
Emmanuel J.1, Ma L.1, Saleh S.1, Wilkinson H.1, Raichura H.1, Wilson L.2
1Royal London Hospital, London, UK, 2Royal London Hospital NHS Trust, London, UK
objeCtives: Reducing readmissions is a National Health Service (NHS) Key 
Performance Indicator. Ambulatory care units may provide financial savings, but 
high quality and effective service delivery is dependent on having an understanding 
of an individual hospital’s admissions. Comparison of patients with single or mul-
tiple comorbidities on admission or in other words multiple admission diagnoses, 
may help plan and deliver appropriate health care and support services in the most 
appropriate setting. We compared patients with multiple admission diagnoses to 
patients with one single admission diagnosis, to investigate whether there are dif-
ferences in patient demographics, length of stay and readmission. Methods: We 
conducted a retrospective audit of all non-elective adult acute medical admissions 
over a 6 week period. We collected information on patient demographics, ICD-10 
diagnosis and length of hospital stay. We reviewed all electronic discharge sum-
maries and grouped admissions according to ICD-10 classification. We matched 
patients with multiple diagnoses to patients with similar ICD-10 diagnosis, without 
other co-morbidities. The length of stay, and readmission rates were also recorded 
and compared. Results: A total of 863 admissions were analysed. We matched 41 
patients with multiple co-morbidities and same admission diagnoses to patients 
discharged with a comparable single ICD-10 diagnosis. Both groups had similar 
female to male ratio. The mean age in both groups was 65 (p= 0.42). However, the 
length of stay was statistically significant (p= 0.002) between the two groups (multi-
ple diagnosis 12 days vs 6 days for single diagnosis). Moreover, patients with multiple 
admission diagnoses had higher readmission rates within a week and a month (0 
patients with single admission diagnosis vs 5 patients with multiple admission diag-
noses). ConClusions: Both groups had similar demographics, but co-morbidities 
can lead to longer hospital stay, and increase risk of hospital readmission. Patients 
with multiple co-morbidities should have more detailed discharged planning by 
multidisciplinary team. Patients without multiple co-morbidites can be safely man-
aged in an ambulatory care setting.
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breAST CAnCer inTegrATed CAre: A rAPid-HTA
Cachoeira C.V., Andrade P.C., Junqueira S.M., Repsold D.M.
Johnson & Johnson Medical, São Paulo, Brazil
objeCtives: Breast cancer is one of the commonest cancers worldwide. The care 
management of patients with cancer is complex, which may lead to suboptimal, 
fragmented and discontinuous treatment. Integrated care pathways have begun 
to receive greater attention and support because of the possibility to reduce this 
fragmentation and achieve better results for the patient and the health care system 
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ies]. ConClusions: PCPDs contribute to improving QOL for patients at the EoL and 
reduce the time they spend in the ICU. This systematic review is part of a mega-
analysis (a multi-intervention appraisal) about EoL care, and its recommendations 
will inform policies regarding the delivering quality EoL care for Ontarians.
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relATionSHiP beTWeen mediCAid eligibiliTy And Time To re-
inCArCerATion of PreviouSly inCArCerATed SubjeCTS WiTH 
SCHizoPHreniA
Benson C.1, Dickson M.2, Kozma C.M.3, Pesa J.A.1
1Janssen Scientific Affairs, LLC, Titusville, NJ, USA, 2Presbyterian College School of Pharmacy, 
Clinton, SC, USA, 3CK Consulting Associates, LLC, St. Helena Island, SC, USA
objeCtives: Many persons with schizophrenia qualify for Medicaid coverage, thus 
prompt re-acquisition of Medicaid eligibility following release from incarceration 
should lower the risk of re-incarceration. The objective of this study was to assess 
the effect of Medicaid eligibility on risk of re-incarceration among schizophrenia 
diagnosed subjects. Methods: Study subjects were selected between 1/1/2006 and 
9/30/2011 from a Medicaid database merged with department of corrections data 
for a single state. Subjects were adults (18-62 years) with diagnosed schizophrenia 
(ICD 9-CM= 295.xx). Covariates included age, race, gender, marital status, and rea-
son for incarceration. Time to Medicaid eligibility post-release, cumulative days of 
eligibility, and eligibility on re-incarceration date were evaluated in two independ-
ent Cox regression models (1 and 3-year followup) evaluating the hazard for re-
incarceration. Results: A total of 932 subjects were included: 26.5% white, 73.7% 
male, 73.5% single/divorced, 12.7% incarcerated for a substance abuse violation, 
average age 37.6 years. Over the one-year follow-up period, 110 subjects (11.8%) were 
re-incarcerated while over three year follow-up, 209 (22.4%) were re-incarcerated. 
Age (in years) was the only significant predictor of re-incarceration for the one 
year model (HR = 0.976, 95% CI 0.957, 0.994). Eligibility was a significant predictor 
in the three-year follow-up model. A longer ‘time to first eligibility’ (HR = 1.046, 95% 
CI= 1.017, 1.075) was associated with a greater hazard for re-incarceration. Being 
Medicaid eligible at the time of re-incarceration (HR= 0.659, 95% CI = 0.498, 0.870), the 
cumulative number of months of eligibility (HR= 0.978, 95% CI= 0.958, 0.997) and age 
were associated with a lower hazard for re-incarceration (HR= 0.986, 95% CI= 0.973, 
0.999). ConClusions: Among schizophrenia diagnosed subjects, Medicaid eligibil-
ity at release and older age were associated with a lower risk of re-incarceration. 
Access to Medicaid and associated health services post-release may be a factor in 
helping to reduce re-incarceration risk.
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mulTi-oPioid, mulTi-Provider uSe in PerSonS WiTHouT CAnCer
Shahpurwala Z.1, Null K.D.1, Clark J.P.2
1University of Mississippi, University, MS, USA, 2Mississippi Division of Medicaid, Jackson, MS, 
USA
objeCtives: Three draft measures have been proposed by the Pharmacy Quality 
Alliance’s Medication Safe Use Workgroup to examine the quality of opioid use 
related to the dose of the medications over time, access to the medications and 
the combination of both of these criteria. The purpose of this study was to conduct 
a sensitivity analysis so as to identify the appropriate thresholds that should be 
utilized in the numerator of these preliminary measures. Methods: Medicaid fee-
for-service beneficiaries aged ≥ 18 years, with continuous 12 month enrollment, 
and two or more prescription claims for opioids that total ≥ 15 days supply on at 
least two separate days during 2012 were identified in the Mississippi Medicaid 
administrative claims data. Representative opioids comprised of those included 
in the ‘CDC Injury Center Morphine Milligram Equivalent (MME) Table.’ Morphine 
Equivalent Dose (MED) was calculated using the following formula: (Submitted 
Quantity*Strength*MME Conversion Factor)/Days Supply. Unique prescribers and 
pharmacies were identified by their national provider identifier number. Results: 
The sample (10,297 beneficiaries) was predominantly female (73.0%), Caucasian 
(52.2%), and had an average age of 44.33 years. 2.6% (6.3%) and 1.9% (5.3%) of the 
beneficiaries received prescriptions for opioids > 100mg MED and > 120mg MED 
respectively, for ≥ 90 consecutive (non-consecutive) days. 21.9% (5.9%) of the benefi-
ciaries received prescriptions for opioids from ≥ 4 prescribers OR (AND) ≥ 4 pharma-
cies. 0.34% (0.11%) and 1.25% (0.42%) beneficiaries received prescriptions for opioids 
> 120mg MED for ≥ 90 consecutive and nonconsecutive days respectively, and from 
≥ 4 prescribers OR (AND) ≥ 4 pharmacies. ConClusions: The sensitivity analysis 
revealed data for critical decision points for the PQA Workgroup. Health plans that 
are considering the adoption of similar measures, in order to plan their respective 
interventions, will benefit from seeing the breakdown.
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dePreSSion And AmbulATory CAre SenSiTive HoSPiTAlizATionS Among 
mediCAre benefiCiArieS WiTH CHroniC PHySiCAl CondiTionS
Bhattacharya R.1, Shen C.2, Sambamoorthi U.3
1West Virginia University, Morgantown, WV, USA, 2The University of Texas MD Anderson Cancer 
Center, Houston, TX, USA, 3West Virginia University School of Pharmacy, Morgantown, WV, USA
objeCtives: We examined the association between depression and Ambulatory 
Care Sensitive Hospitalizations (ACSH) among Medicare beneficiaries. Methods: 
We adopted a retrospective cross-sectional design using merged survey and fee-for-
service Medicare claims data from 2002-2009 Medicare Current Beneficiary Survey. 
Our study sample consisted of community-dwelling fee-for-service Medicare enroll-
ees with any of the following chronic conditions: arthritis, cancer, diabetes, heart 
disease, hypertension, respiratory diseases, and osteoporosis. ACSH and depression 
were identified using ICD-9-CM Codes. The dependent variables were: any “chronic 
ACSH” (diabetes short-term complications, diabetes long-term complications, 
chronic obstructive pulmonary disease (COPD), hypertension, congestive heart fail-
ure (CHF), angina without a procedure, uncontrolled diabetes, adult asthma and/or 
lower extremity amputations) and “acute ACSH” (dehydration, bacterial pneumonia 
and/or urinary infections), and “any ACSH”. We separately examined ACSH for CHF, 
objeCtives: Determine the factors influencing mammography prescription dur-
ing physician office visits in the U.S and to also determine whether primary care 
physicians or gynecological practitioners have a higher likelihood of prescribing 
mammograms. The study will also examine the possible change in the likelihood 
of mammography prescription over time for different age groups during 2008-2010 
as a result of the 2009 USPSTF screening recommendations. Methods: This cross-
sectional study uses data from National Ambulatory Medical Care Survey. The study 
sample consists of female patients > 40 years, who had a physician office visit in 
the US during 2008-2010. Women with current diagnosis of breast cancer were 
excluded from the study. Logistic regressions were used for the analysis. Results: 
Women visiting a physician for preventive care were approximately eight times 
more likely to be prescribed a mammogram (OR:7.916, 95%CI:4.697-13.340). Women 
residing in non-metropolitan statistical areas were less likely to be prescribed a 
mammogram (OR:0.461, 95%CI:0.238-0.893). Mammography prescription by physi-
cians did not vary by race-ethnicity, insurance coverage, region of residence and 
time spent with the physician. As compared to primary care physicians, obstetrics 
and gynecologist were two times more likely to prescribe a mammogram (OR:2.713 
95%CI:1.395-5.277). In the year 2008 and 2010, there were no statistically significant 
differences in mammography prescriptions across age groups. However in 2009, 
women aged 50-54 (OR:2.053 95%CI:1.061-3.975), 55-59 (OR:2.085 95%CI:1.063-4.089), 
60-64 (OR:2.037 95%CI:1.100-3.775) and 70-74 (OR:2.511 95%CI:1.047-6.026) were two 
times more likely to get a mammography prescription as compared to 40-49 year 
old women. ConClusions: Physician specialty, nature of visit and residence in 
metropolitan statistical areas are important determinants of receiving a mammog-
raphy prescription. In the year 2009 there was a fall in mammography prescription 
for 40-49 year old women as compared to older age groups, however this drop did 
not persist in 2010.
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THe imPACT of miSSed CliniC APPoinTmenTS on THe QuAliTy of 
AnTiCoAgulATion ConTrol in An inner-CiTy underServed minoriTy 
PoPulATion
Sarangpur S., Sharp L., Gerber B., Schumock G.T., Fitzgibbon M.L., Cavallari L.H., Bathija S., 
Nutescu E.
University of Illinois at Chicago, Chicago, IL, USA
objeCtives: The aim of this study was to evaluate the impact of missed clinic 
appointments on the time in therapeutic international normalized ratio range (TTR) 
in an inner-city underserved minority population. Methods: A cross-sectional 
survey and cohort study were conducted in patients treated with warfarin and 
managed at the University of Illinois at Chicago Antithrombosis Clinic. Patient 
social, demographic, and clinical characteristics were compared using paramet-
ric and non-parametric tests as appropriate and weighted linear regression using 
propensity scores was performed to identify the association between patients with 
≥ 15% missed clinic appointments and TTR. Results: A total of 291 consecutive 
patients responded to the survey and were included in the study. Patients with ≥ 
15% missed clinic appointments had lower mean age (51.36 ± 17.62 vs. 57.18 ± 16.97, 
p = 0.0051), lower TTR (44.97 ± 19.63 vs. 53.25 ± 20.36 p = 0.0007), a higher number of 
total clinic appointments for monitoring (21.25 ± 8.37 vs. 16.28 ± 7.73, p = < 0.0001), 
higher non-adherence with warfarin therapy (16.10 ± 14.02 vs. 10.22 ± 12.85, p = 
< 0.0001) and longer duration of therapy (4.38 ± 5.91 years vs. 2.71 ± 3.26 years, p = 
0.0009) compared to patients with < 15% missed clinic appointments. Based on the 
results of the unadjusted bivariate regression model, patients with ≥ 15% missed 
clinic appointments had significantly lower TTR (β = -8.43, 95% CI: -13.10, -3.76, p 
= 0.0004). After adjusting for confounders using inverse probability weights, the 
association between missed clinic appointments and TTR remained significant (β = 
-6.30, 95% CI: -11.18, -1.42, p = 0.0115). ConClusions: Missed clinic appointments 
for anticoagulation management negatively affected the quality of anticoagula-
tion control. Future studies should evaluate factors associated with missed clinic 
appointments and the feasibility of more accessible high-quality models of care in 
underserved minorities.
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effeCTiveneSS of PATienT CAre PlAnning diSCuSSionS in imProving 
PATienT-CenTred ouTComeS for end-of-life CAre: An evidenCe-bASed 
AnAlySiS
Baidoobonso S.M.1, Holubowich C.2
1Health Quality Ontario, Toronto, ON, Canada, 2on behalf of the Expert Panel on End-of-Life Care, 
Health Quality Ontario, Toronto, ON, Canada
objeCtives: This evidence-based analysis (EBA) is a systematic review of the effec-
tiveness of patient care planning discussions (PCPDs) between patients/ families 
and providers in improving patient-centred outcomes for people nearing the end 
of life (EoL). Methods: A literature search was performed using MEDLINE, Embase, 
CINAHL, and EBM Reviews for studies published from January 1, 2004 to October 9, 
2013. Included studies must be in English, include adults at the EoL, utilize selected 
study designs [i.e. randomized controlled trials (RCTs), observational studies, sys-
tematic reviews, meta-analyses], and focus on discussion-based interventions for 
planning EoL care. Titles and abstracts were reviewed by a single reviewer and full-
text articles were obtained when appropriate. Reference lists were examined for 
additional relevant studies. The quality of the evidence was evaluated using GRADE. 
When appropriate, meta-analyses were performed. Results: The search yielded 
5,316 citations, and 13 RCTs and 17 observational studies were selected for inclusion 
in the quantitative evidence synthesis, which is still underway. Preliminary results 
showed that, compared to no PCPDs, PCPDs involving providers from at least one 
discipline led to increases in quality of life (QOL). Interventions that included tools 
to facilitate PCPDs (e.g. question list) did not perform better than their controls (2 
studies showing mean differences of 0.01, p> 0.05 and 0.10, p> 0.05). Having PCPDs 
earlier in the illness course was associated with higher QOL (adjβ = 0.003, p= 0.006; 
1 study). PCPDs with a multidisciplinary team of providers led to fewer days in 
the intensive care unit (ICU) [pooled estimate: -6.68 (95% CI: -10.71, -2.65); 2 stud-
